Producing insulin in state could help to lower the price for California residents with diabetes in the 3 years following implementation of the CalRx initiative. The price of insulin has been a primary ...

Pharmaceutical companies layer on patents for drug delivery devices to maintain market exclusivity, according to a new study.

Biocon Biologics is among the leading global suppliers of biosimilar insulins and has been expanding its portfolio ...

Lawmakers in Lansing began considering bills last week that would allow the state to partner with a private manufacturer to produce and distribute low-cost generic insulin. The state House Health ...

Two years ago, California made a bold announcement that it would manufacture a state-branded, low-cost insulin. Drug manufacturers, insurers, economists and diabetics took notice. It had the potential ...

This story was originally published on Grocery Dive. To receive daily news and insights, subscribe to our free daily Grocery Dive newsletter. Sprouts Farmers Market is the latest major company to file ...

DOWNEY -- The state of California and a generic drug manufacturer announced a 10-year partnership Saturday to produce affordable, state-branded insulin that they hope will rival longtime producers and ...

California Gov. Gavin Newsom announced on Saturday that the state will cut insulin costs by 90% and that it will start manufacturing naloxone, a nasal spray used to reverse opioid overdoses. The lower ...

A lower-cost insulin manufacturer has taken the next step toward establishing a location in West Virginia. UNDBIO, a South Korean company, has secured a lease with West Virginia University to build an ...

Diabetes is the most expensive chronic condition in the U.S., and one in three Americans is at risk of developing the disease in their lifetime, according to data compiled by the Centers for Disease ...

NEW YORK – New York Attorney General Letitia James has secured an agreement with one of the nation’s largest insulin manufacturers, Novo Nordisk Inc. to cap the price of insulin at $35 per monthly ...

Drugmaker Eli Lilly warned this week that two of its formulations of insulin would be temporarily out of stock through the beginning of April, citing a “brief delay in manufacturing.” The ...